Medikra Inc. (MDKR)
| Market Cap | 160.55M |
| Revenue (ttm) | 16,099 -61.7% |
| Net Income | -776,370 |
| EPS | -0.03 |
| Shares Out | 29.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About MDKR
Medikra is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade botanical therapeutics. Through its wholly owned Malaysian subsidiary, Medika Natura Sdn. Bhd., the Company has established an integrated discovery and development platform that combines proprietary botanical extraction, preclinical and clinical trials, and multi-omics research. This platform aims to transform traditional medicinal plants into scientifically tested therapies aligned with international regula... [Read more]
News
Malaysia-based obesity biotech Medikra files and sets terms for a $20 million US IPO
Medikra, a Malaysia-based developer of plant-based bioactives focused on obesity and metabolic syndrome, filed on Tuesday with the SEC to raise up to $20 million in an initial public offering.
Medikra IPO Registration Document (F-1)
Medikra has filed to go public with an IPO on the NYSE American